297 related articles for article (PubMed ID: 8624080)
1. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.
Beffert U; Poirier J
Ann N Y Acad Sci; 1996 Jan; 777():166-74. PubMed ID: 8624080
[TBL] [Abstract][Full Text] [Related]
2. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
[TBL] [Abstract][Full Text] [Related]
3. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
Landén M; Thorsell A; Wallin A; Blennow K
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Poirier J; Delisle MC; Quirion R; Aubert I; Farlow M; Lahiri D; Hui S; Bertrand P; Nalbantoglu J; Gilfix BM; Gauthier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12260-4. PubMed ID: 8618881
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation.
März W; Scharnagl H; Kirça M; Bohl J; Gross W; Ohm TG
Ann N Y Acad Sci; 1996 Jan; 777():276-80. PubMed ID: 8624098
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.
Ohm TG; Kirca M; Bohl J; Scharnagl H; Gross W; März W
Neuroscience; 1995 Jun; 66(3):583-7. PubMed ID: 7644022
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and Alzheimer's disease.
Strittmatter WJ; Roses AD
Annu Rev Neurosci; 1996; 19():53-77. PubMed ID: 8833436
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.
Mahley RW; Nathan BP; Pitas RE
Ann N Y Acad Sci; 1996 Jan; 777():139-45. PubMed ID: 8624076
[TBL] [Abstract][Full Text] [Related]
11. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
[TBL] [Abstract][Full Text] [Related]
12. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
13. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients.
Sparks DL; Scheff SW; Liu H; Landers T; Danner F; Coyne CM; Hunsaker JC
J Neurol Sci; 1996 Jun; 138(1-2):97-104. PubMed ID: 8791246
[TBL] [Abstract][Full Text] [Related]
14. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.
Morris CM; Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Torvik A; Bjertness E; Edwardson JA
Neurosci Lett; 1995 Dec; 201(1):45-7. PubMed ID: 8830309
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.
Poduri A; Gearing M; Rebeck GW; Mirra SS; Tigges J; Hyman BT
Am J Pathol; 1994 Jun; 144(6):1183-7. PubMed ID: 8203459
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia.
Bancher C; Egensperger R; Kösel S; Jellinger K; Graeber MB
Acta Neuropathol; 1997 Nov; 94(5):403-9. PubMed ID: 9386771
[TBL] [Abstract][Full Text] [Related]
17. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
18. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
19. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.
Berr C; Hauw JJ; Delaère P; Duyckaerts C; Amouyel P
Neurosci Lett; 1994 Sep; 178(2):221-4. PubMed ID: 7824200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
